Note 6 - Intangibles

12 Months Ended

Oct. 01, 2016

Notes to Financial Statements

Intangible Assets Disclosure [Text Block]

6.

INTANGIBLES

	2016			2015
Patents and trademarks	$	2,268,402		$	2,203,673
Trade names		343,678			342,416
Non-competition agreements		150,601			150,048
Customer relationships		2,526,230			2,516,952
		5,288,911			5,213,089
Less accumulated amortization		(3,299,012	)		(2,998,327	)
Net intangibles	$	1,989,899		$	2,214,762

On

December

9,

2011,

we acquired, through a new wholly - owned subsidiary, substantially all of the assets of old M.C. Healthcare and acquired intangibles of approximately

$3,980,000.

At

October

1,

2016

and

October

3,

2015

we had intangibles associated with the asset acquisition of M.C. Healthcare of trade names, non - competition agreements and customer relationships (net of accumulated amortization of

$1,367,399

and

$1,115,246,

respectively) of

$1,653,110

and

$1,894,170,

respectively. Changes in the balances shown for trade names, non - competition agreements and customer relationships result solely from foreign currency fluctuations.

In addition, we had patents and trademarks (net of accumulated amortization) of

$

336,789

 

as of

October

1,

2016

and

$320,592

as of

October

3,

2015.

We reviewed the useful lives of individual patents and trademarks and determined that the useful lives did not require any material changes. The intangibles and the patents and trademarks are primarily associated with the medical segment.

Amortization expense for intangibles, patents and trademarks during fiscal years

2016,

2015

and

2014

was

$295,092,

$326,775

and

$394,169,

respectively. Estimated amortization expense for the next

five

fiscal years based on existing intangibles is as follows:

	Estimated
	Amortization
Fiscal Years	Expense
2017	$	285,000
2018		278,000
2019		276,000
2020		276,000
2021		273,000